Akari Therapeutics and Whitehawk Expand Dual-Payload ADC Strategy
Tampa, Florida and London, United Kingdom — August 13, 2026 Akari Therapeutics, Plc reported progress on its lead antibody-drug...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Tampa, Florida and London, United Kingdom — August 13, 2026 Akari Therapeutics, Plc reported progress on its lead antibody-drug...
Tampa, Florida, USA & London, UK | July 21, 2026 Akari Therapeutics announced a strategic research collaboration with Whitehawk...
ZURICH, Switzerland, July 13, 2026 VERAXA Biotech announced a strategic collaboration with AI-driven computational biology company Ardigen to accelerate...
CAMBRIDGE, Mass., ROTTERDAM, Netherlands, and SHANGHAI, China, June 15, 2026 Harbour BioMed and BioMap have announced a long-term strategic...
WALNUT CREEK, California, USA & SUZHOU, China | June 3, 2026 Dark Horse Consulting Group (DHCG) and Altruist Biologics...
WARSAW, Poland, June 3, 2026 Ingenix, an emerging artificial intelligence company focused on transforming drug discovery through advanced biological...
NEW YORK, SAN FRANCISCO, and SUZHOU, China, May 28, 2026 Pfizer Inc. and Innovent Biologics have announced a landmark...
North Chicago, Ill., USA – May 21, 2026 AbbVie announced new oncology research findings ahead of the 2026 American...
Redmond, Washington, USA – May 21, 2026 SystImmune, Inc. announced that multiple clinical and late-stage development data sets from...
MUMBAI, India and TOKYO, Japan, April 16, 2026 Piramal Pharma Solutions (PPS) and Ajinomoto Bio-Pharma Services have announced a...
